
Featured
**FDA's August Drug Approval Surge Masks Looming NIH Funding Crisis
The FDA approved seven breakthrough therapies in August 2026, including gene therapies for ultra-rare diseases, even as NIH faces a devastating 40% bu...
Read Full Story →Explore our comprehensive coverage of drug approvals, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

The FDA approved seven breakthrough therapies in August 2026, including gene therapies for ultra-rare diseases, even as NIH faces a devastating 40% bu...
Read Full Story →